Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects
Authors:
- 28 February 2019
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 103 (11) , 1600-1604
Abstract
Background/Aims Hydroxychloroquine (HCQ) retinopathy may result in severe and irreversible vision loss, emphasising the importance of screening and early detection. The purpose of this study is to report the novel finding of early optical coherence tomography (OCT) abnormalities due to HCQ toxicity that may develop in the setting of normal Humphrey visual field (HVF) testing. Methods Data from patients with chronic HCQ exposure was obtained from seven tertiary care retina centres. Ten patients with HCQ-associated OCT abnormalities and normal HVF testing were identified. Detailed analysis of the OCT findings and ancillary tests including colour fundus photography, fundus autofluorescence, multifocal electroretinography and microperimetry was performed in these patients. Results Seventeen eyes from 10 patients illustrated abnormalities with OCT and normal HVF testing. These OCT alterations included (1) attenuation of the parafoveal ellipsoid zone and (2) loss of a clear continuous interdigitation zone. Several eyes progressed to advanced parafoveal outer retinal disruption and/or paracentral visual field defects. Conclusion Patients with high risk HCQ exposure and normal HVF testing may develop subtle but characteristic OCT abnormalities. This novel finding indicates that, in some cases of early HCQ toxicity, structural alterations may precede functional impairment. It is therefore important to employ a screening approach that includes OCT to assess for these early findings. Ancillary testing should be considered in cases with suspicious OCT changes and normal HVFs.Keywords
Funding Information
- Macula Foundation, Inc.
- Research to Prevent Blindness
This publication has 19 references indexed in Scilit:
- Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessationInternational Journal of Retina and Vitreous, 2016
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology, 2016
- A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathyDocumenta Ophthalmologica, 2014
- A subtle case of hydroxychloroquine retinopathy: spectral domain optical coherence tomography findingsEye, 2014
- Effect of Disease Stage on Progression of Hydroxychloroquine RetinopathyJAMA Ophthalmology, 2014
- Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathyClinical Ophthalmology, 2014
- Disparity between Visual Fields and Optical Coherence Tomography in Hydroxychloroquine RetinopathyOphthalmology, 2014
- Comparison of Screening Procedures in Hydroxychloroquine ToxicityArchives of Ophthalmology (1950), 2012
- Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign)Clinical Ophthalmology, 2010
- Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescenceBritish Journal of Ophthalmology, 2009